ALaSCA: A novel in silico simulation platform to untangle biological pathway mechanisms, with a case study in Type 1 Diabetes progression
Carla Louw, Nina Truter, Wikus Bergh, Martine van den Heever, Shade Horn, Radouane Oudrhiri, Dawie van Niekerk, Ben Loos, Raminderpal Singh
This paper introduces ALaSCA, a causal analysis platform, and applies it to study antioxidant protein effects on Type 1 Diabetes progression using proteomic data.
bioRxiv · Mar 16, 2023 · PreprintBioinformatics